Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Stroes

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Medical Research and Opinion|September 6, 2005
Statins and LDL-cholesterol lowering: an overviewErik Stroes
Atherosclerosis. Supplements|April 25, 2017
How to assess and manage cardiovascular risk associated with lipid alterations beyond LDLMaurizio Averna, Erik Stroes,
Current Opinion in HIV and AIDS|April 18, 2009
Drug interactions between statins and antiretroviral agentsDavid Burger, Erik Stroes, Peter Reiss
European Heart Journal|November 13, 2013
The gut microbiome as novel cardio-metabolic target: the time has come!Sarah Vinjé, Erik Stroes, Max Nieuwdorp, et al.
Clinical Endocrinology|June 15, 2007
Inherited lipodystrophies and the metabolic syndromeHoushang Monajemi, Erik Stroes, Robert A Hegele, et al.
Seminars in Thrombosis and Hemostasis|April 9, 2008
Metabolic modulation of inflammation-induced activation of coagulationMarcel Levi, Max Nieuwdorp, Tom van der Poll, et al.
Atherosclerosis. Supplements|December 22, 2016
Diagnostic algorithm for familial chylomicronemia syndromeErik Stroes, Philippe Moulin, Klaus G Parhofer, et al.
Cardiovascular Drugs and Therapy|September 14, 2016
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or HigherHenry N Ginsberg, Daniel J Rader, Frederick J Raal, et al.
Clinical Cardiology|August 19, 2018
Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studiesErik Stroes, Jennifer G Robinson, Frederick J Raal, et al.
Atherosclerosis|March 13, 2017
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiencyElisabeth Steinhagen-Thiessen, Erik Stroes, Handrean Soran, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Medical Research and Opinion|September 6, 2005
Statins and LDL-cholesterol lowering: an overviewErik Stroes
Atherosclerosis. Supplements|April 25, 2017
How to assess and manage cardiovascular risk associated with lipid alterations beyond LDLMaurizio Averna, Erik Stroes,
Current Opinion in HIV and AIDS|April 18, 2009
Drug interactions between statins and antiretroviral agentsDavid Burger, Erik Stroes, Peter Reiss
European Heart Journal|November 13, 2013
The gut microbiome as novel cardio-metabolic target: the time has come!Sarah Vinjé, Erik Stroes, Max Nieuwdorp, et al.
Clinical Endocrinology|June 15, 2007
Inherited lipodystrophies and the metabolic syndromeHoushang Monajemi, Erik Stroes, Robert A Hegele, et al.
Seminars in Thrombosis and Hemostasis|April 9, 2008
Metabolic modulation of inflammation-induced activation of coagulationMarcel Levi, Max Nieuwdorp, Tom van der Poll, et al.
Atherosclerosis. Supplements|December 22, 2016
Diagnostic algorithm for familial chylomicronemia syndromeErik Stroes, Philippe Moulin, Klaus G Parhofer, et al.
Cardiovascular Drugs and Therapy|September 14, 2016
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or HigherHenry N Ginsberg, Daniel J Rader, Frederick J Raal, et al.
Clinical Cardiology|August 19, 2018
Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studiesErik Stroes, Jennifer G Robinson, Frederick J Raal, et al.
Atherosclerosis|March 13, 2017
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiencyElisabeth Steinhagen-Thiessen, Erik Stroes, Handrean Soran, et al.
Pageof 5